These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 5678057)
1. Reduction of Factor VIII activity in cryoprecipitate obtained from acidified plasma. Gilchrist GS; Ekert H Transfusion; 1968; 8(5):294-8. PubMed ID: 5678057 [No Abstract] [Full Text] [Related]
2. Dose requirement for replacement therapy in hemophilia A. Allain JP Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of the antihemophilic cryoprotein from the acidified plasma. I]. Vlcková M; Vopatová M Vnitr Lek; 1972 Aug; 18(8):795-800. PubMed ID: 5054177 [No Abstract] [Full Text] [Related]
4. Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia. Bennett E; Dormandy KM; Churchill WG; Coward AR; Smith M; Cleghorn TE Br Med J; 1967 Apr; 2(5544):88-91. PubMed ID: 6020855 [No Abstract] [Full Text] [Related]
5. DDAVP and cryoprecipitate in mild haemophilia. Boulton FE; Smith A Lancet; 1979 Sep; 2(8141):535. PubMed ID: 90263 [No Abstract] [Full Text] [Related]
6. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate. Oberman HA; Penner JA JAMA; 1968 Sep; 205(12):819-21. PubMed ID: 5695503 [No Abstract] [Full Text] [Related]
7. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program. Smith KJ; Hodges PA Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840 [TBL] [Abstract][Full Text] [Related]
8. Clearance of cryoprecipitated factor VIII in canine hemophilia A. Aufderheide WM; Skinner SF; Kaneko JJ Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873 [TBL] [Abstract][Full Text] [Related]
9. Fractions rich in factor VIII. Biggs R Bibl Haematol; 1968; 29():1122-6. PubMed ID: 5750137 [No Abstract] [Full Text] [Related]
10. Concentrated antihemophilic factor (AHF) from outdated blood. Weaver RA; Gabriel DA; Langdell RD Transfusion; 1967; 7(3):168-73. PubMed ID: 6025692 [No Abstract] [Full Text] [Related]
11. The effect of cryoprecipitate concentrate in patients with classical haemophilia. Barrett KE; Israëls MC; Burn AM Lancet; 1967 Jan; 1(7483):191-2. PubMed ID: 4163324 [No Abstract] [Full Text] [Related]
13. A high-potency, single-donor cryoprecipitate of known factor VIII content dispensed in vials. McLeod BC; Sassetti RJ; Cole ER; Scott JP Ann Intern Med; 1987 Jan; 106(1):35-40. PubMed ID: 3098152 [TBL] [Abstract][Full Text] [Related]
14. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate. Weiss HJ; Rogers J Am J Med; 1972 Dec; 53(6):734-8. PubMed ID: 4539018 [No Abstract] [Full Text] [Related]
15. Production of high-potency cryoprecipitate from exercised blood donors and the treatment of hemophilia A with this material. Strand CL; Beene JR; Geiger T; Eckel MO; Kunkel K; Bull G Am J Clin Pathol; 1974 Oct; 62(4):496-501. PubMed ID: 4415312 [No Abstract] [Full Text] [Related]
16. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties]. Lopaciuk S; Naleczyńska A; Klenowska Z; Daszyński J; Pawelski S Pol Tyg Lek; 1969 Jun; 24(22):826-9. PubMed ID: 5802316 [No Abstract] [Full Text] [Related]
17. [Therapeutic value of cryoprecipitate in hemophilia A]. Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749 [No Abstract] [Full Text] [Related]